Cargando…
Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy
Oncolytic virotherapy (OVT) is a novel type of immunotherapy that induces anti-tumor responses through selective self-replication within cancer cells and oncolytic virus (OV)-mediated immunostimulation. Notably, talimogene laherparepvec (T-Vec) developed by the Amgen company in 2015, is the first FD...
Autores principales: | Ban, Weiyue, Guan, Jianhuan, Huang, Hanwei, He, Zhonggui, Sun, Mengchi, Liu, Funan, Sun, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tsinghua University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852960/ https://www.ncbi.nlm.nih.gov/pubmed/35194488 http://dx.doi.org/10.1007/s12274-021-4031-6 |
Ejemplares similares
-
Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy
por: Ban, Weiyue, et al.
Publicado: (2023) -
Self-assembled short peptides: Recent advances and strategies for potential pharmaceutical applications
por: Yang, Shihua, et al.
Publicado: (2023) -
Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime
por: Sun, Mengchi, et al.
Publicado: (2022) -
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
por: Wang, Gang, et al.
Publicado: (2020) -
Oncolytic immunotherapy for metastatic cancer: lessons and future strategies
por: Guo, Zong-Sheng
Publicado: (2020)